about
Risk Factors for Intracranial Hemorrhage in Acute Ischemic Stroke Patients Treated With Recombinant Tissue Plasminogen Activator: A Systematic Review and Meta-Analysis of 55 StudiesCorticosteroids for acute ischaemic strokePhysical methods for preventing deep vein thrombosis in strokeSurgery for cervical radiculopathy or myelopathyAnticoagulants for preventing recurrence following presumed non-cardioembolic ischaemic stroke or transient ischaemic attackAntiplatelet therapy for acute ischaemic strokeThe benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trialFatigue after stroke: baseline predictors and influence on survival. Analysis of data from UK patients recruited in the International Stroke TrialInflammatory markers and poor outcome after stroke: a prospective cohort study and systematic review of interleukin-6."Can it read my mind?" - What do the public and experts think of the current (mis)uses of neuroimaging?Planning trials in older patients with stroke: data from the International Stroke Trial.The authors say: 'The data are not so robust because of heterogeneity' - so, how should I deal with this systematic review? Meta-analysis and the clinician.Update on the third international stroke trial (IST-3) of thrombolysis for acute ischaemic stroke and baseline features of the 3035 patients recruitedFactors affecting the apparent efficacy and safety of tissue plasminogen activator in thrombotic occlusion models of stroke: systematic review and meta-analysisAssociation of circulating inflammatory markers with recurrent vascular events after stroke: a prospective cohort study.Length of carotid stenosis predicts peri-procedural stroke or death and restenosis in patients randomized to endovascular treatment or endarterectomyThe International Stroke Trial databaseDoes intermittent pneumatic compression reduce the risk of post stroke deep vein thrombosis? The CLOTS 3 trial: study protocol for a randomized controlled trial.Clinical and imaging services for TIA and minor stroke: results of two surveys of practice across the UK.Blood biomarkers in the diagnosis of ischemic stroke: a systematic review.Endovascular treatment with angioplasty or stenting versus endarterectomy in patients with carotid artery stenosis in the Carotid and Vertebral Artery Transluminal Angioplasty Study (CAVATAS): long-term follow-up of a randomised trialLong-term risk of carotid restenosis in patients randomly assigned to endovascular treatment or endarterectomy in the Carotid and Vertebral Artery Transluminal Angioplasty Study (CAVATAS): long-term follow-up of a randomised trial.Blood markers for the prognosis of ischemic stroke: a systematic review.Should mechanical embolectomy devices be used in routine clinical practice?Blood biomarkers for the diagnosis of acute cerebrovascular diseases: a prospective cohort study.Negative results: why do they need to be published?Why calls for more routine carotid stenting are currently inappropriate: an international, multispecialty, expert review and position statement.Does intermittent pneumatic compression reduce the risk of post stroke deep vein thrombosis? The CLOTS 3 trial: statistical analysis plan.Does acetyl salicylic acid (ASA) have a role in the prevention of venous thromboembolism?Intermittent pneumatic compression in patients with stroke--authors' reply.Is the 'liberation procedure' for multiple sclerosis really liberating?The effect of graduated compression stockings on long-term outcomes after stroke: the CLOTS trials 1 and 2.Statistical analysis plan for the third International Stroke Trial (IST-3); part of a 'thread' of reports of the trial.How to do high-quality clinical research 1: First steps.Effects of alteplase for acute stroke according to criteria defining the European Union and United States marketing authorizations: Individual-patient-data meta-analysis of randomized trials.Blood pressure variability and leukoaraiosis in acute ischemic stroke.Protocol for the perfusion and angiography imaging sub-study of the Third International Stroke Trial (IST-3) of alteplase treatment within six-hours of acute ischemic stroke.The Johann Jakob Wepfer Award 2010 of the European Stroke Conference to Professor Jan van Gijn.'Yes' or 'no' to routine statins after subarachnoid hemorrhage to prevent delayed cerebral ischaemia, vasospasm, and death? A cautionary tale of 2 meta-analyses.Should more patients with acute ischaemic stroke receive thrombolytic treatment?
P50
Q22306325-3321C69A-7282-42CB-A98E-DA3EB0620A27Q24234485-E6AA566E-E1FC-4586-B4E3-67CC1F3E6EF8Q24236547-6206179D-157E-4089-B434-48F5762B194CQ24240841-9E87493D-7CE0-4151-B224-1C589814DCCEQ24241777-5E3CCE9E-1815-451E-9679-4F1460927C8EQ24242725-B11659C6-17DF-4668-A19D-FC07513A4D44Q24595579-A7C9B942-5B33-4CF1-975C-2136A06C172AQ30000955-B792947A-BA90-4046-AF98-F3E9A1C8597BQ30878935-5062ABB8-09DA-45AA-81B3-8AD47DEC4325Q31032689-75235FAF-D28B-4999-8D65-4423C51681A0Q33857355-0D27C61C-4DE3-44FB-8658-E8D0AFAD7E62Q33873266-BD58C760-DE1D-48E7-A970-4342E7B2C712Q34086851-9E52C77C-EF23-4146-83C9-F61497E5F25BQ34410346-4FB99FDF-56C9-4AA8-8518-00FFD28518F5Q34469067-9ED92EE0-E017-478C-88B1-2AD0DB175E12Q34511338-2FA90E21-77CC-4A7E-96AA-BF9D06C6D599Q35014931-5355C2C3-96B3-4E20-A225-08AF04B6034DQ35870454-092E91BE-F06E-4E41-9A86-755DD670B071Q37086986-44A56C0A-A6DB-45A9-93A2-363357EF8811Q37227913-DB1F935D-0859-44A5-AE2F-A1F0BF47FCC2Q37370109-187D80B0-6D10-44A8-A91E-1BB12456FC3BQ37370115-81F83F5E-4A38-4BE5-B2F6-3CD5C15070E8Q37415033-00D07047-EEA8-4897-8F42-B611A7D6E5DDQ37845200-03330A6E-01E1-4DDE-AC51-EDF2CFAB68C8Q37903591-1833D314-3CE5-407E-B29D-1079CBD0EA20Q37970510-77AE693C-E1AE-4202-A0B3-A96C2A631FEBQ38091405-060B2F09-8004-4317-AE63-C62C9CAC7307Q40763526-2A78DA31-13F6-4EF6-8D74-F3B6247C35B1Q43266381-E634630D-4FD0-426C-95D6-BFAB3E4F7003Q44929989-5B376321-3B97-4144-8E85-BC873EA11C17Q44958976-553D62F2-9587-42D3-B865-B431E1D83908Q45823505-37E6CEA2-02FB-4654-9453-B89B8DE5B807Q46171085-7E8C70CE-5D13-46DD-8853-7E83CF8F026EQ47211092-0652E5C7-853D-41F3-A147-5763D3051197Q47420086-2A92D249-2E3D-4EA0-9697-BA2A06BB993BQ47700304-3BFA7367-2AE6-4B23-B1BE-D0EE29732EF5Q48201145-8616D6F5-A429-4109-BAEA-3166B7CB8674Q48306565-D1563B2C-90BF-490B-96AF-8A2AF08670F6Q48390263-345DEBD8-2658-49FB-B7CC-5D1831658E0CQ48410859-D99F6F0A-5593-432E-B2D4-C01744B88134
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Peter Sandercock
@ast
Peter Sandercock
@en
Peter Sandercock
@es
Peter Sandercock
@nl
Peter Sandercock
@sl
type
label
Peter Sandercock
@ast
Peter Sandercock
@en
Peter Sandercock
@es
Peter Sandercock
@nl
Peter Sandercock
@sl
prefLabel
Peter Sandercock
@ast
Peter Sandercock
@en
Peter Sandercock
@es
Peter Sandercock
@nl
Peter Sandercock
@sl
P106
P21
P2798
P31
P496
0000-0001-8484-0135